Northwest Biotherapeutics said Wednesday it is expanding clinical tests of a potential brain cancer vaccine after early trials suggested it can help patients with the most aggressive form of the disease. The Bothell company said early trials indicate patients may survive twice as long as those taking either of two approved drugs.
CombiMatrix loses $12.4 million in ‘05
Mukilteo’s CombiMatrix Corp. lost $12.4 million in 2005 compared to a net income of $710,000 in the previous year, the company reported. The biotechnology firm said its 2005 revenue was $8 million, down sharply from $19.6 million in 2004. The previous year’s revenue figure included a $17.3 million payment from Roche, a contract partner of CombiMatrix.
Omnimedia reports a profit for Stewart
Martha Stewart Living Omnimedia Inc. swung to a fourth-quarter profit, helped by a continued rebound in advertising revenue at its flagship Martha Stewart Living magazine. The company’s shares rose 71 cents, or 4.3 percent, to $17.20 in early trading on the New York Stock Exchange. The New York-based multimedia company said Wednesday it posted net income of $2.95 million, or 6 cents per share, for the three-month period ended Dec. 31. That compares with a loss of $7.33 million, or 15 cents a share, in the same period the previous year.
Google, EarthLink team up on wireless
Google Inc. is joining EarthLink Inc. in a bid to build a wireless network in San Francisco that would offer basic Internet access for free and charge about $20 per month to surf the Web at higher speeds. Google, which runs the Internet’s leading search engine, and EarthLink, a major Internet service provider, had been bidding against each other but recently decided it made more sense to team up.
Merger costs drag down Sprint Nextel
Sprint Nextel Corp. on Wednesday reported a 55 percent drop in fourth-quarter income, dragged down largely by expenses related to a merger last year that created the company. The telecommunications carrier also forecast that its 2006 revenue will be $41 billion or more, while the average estimate has been $46.8 billion. Its shares fell $1.13, or 4.5 percent, to close at $23.80 Wednesday on the New York Stock Exchange.
From Herald staff and news services
Talk to us
> Give us your news tips.
> Send us a letter to the editor.
> More Herald contact information.
